ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1117

Discontinuities in Transplant Waiting Times, Allograft Quality, and Post-Transplant Outcomes Associated with Expected Post-Transplant Survival-Based Cutoff for Longevity Matching

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical

Authors

  • Joseph, Zachary I., Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States
  • Yu, Miko, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States
  • Schold, Jesse D., University of Colorado System, Denver, Colorado, United States
  • Mohan, Sumit, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States

Group or Team Name

  • Columbia University Renal Epidemiology (CURE) Lab
Background

In organ allocation, longevity matching is the practice of allocating longer-lasting organs to patients with greater expected post-transplant survival. In kidney transplantation in the U.S., this is implemented using Expected Post-transplant Survival (EPTS) scores: patients with EPTS ≤ 20 receive priority during the allocation of deceased donor kidneys with Kidney Donor Profile Index (KDPI) ≤20. The impact of this eligibility cutoff on waiting list and post-transplant outcomes remains unclear.

Methods

Using UNOS registry data, we identified adult patients listed for kidney-only transplants from 2015 to 2025 and calculated transplant rates by EPTS at listing. For deceased donor kidney recipients, we performed median regression for KDPI of allograft received and a Cox proportional hazards analysis for the event of graft failure or death, using EPTS at transplant and an indicator for EPTS > 20 as explanatory variables.

Results

Among 331,971 eligible patients, transplant rates were significantly lower for patients with initial EPTS 21–25 versus 16–20 (27.21 vs. 30.05 transplants per 100 patient-years, p<0.001). Among the 108,686 eligible deceased donor kidney recipients, loss of longevity matching eligibility was associated with a 16.2-point increase in median KDPI of allograft received (p<0.001) and a 21% greater hazard of graft failure or death (p<0.005).

Conclusion

The current implementation of longevity matching introduces discontinuities in transplant rates, allograft quality, and post-transplant outcomes for patients with EPTS near 20. These findings support consideration of alternative implementations of longevity matching.

Funding

  • NIDDK Support